There were 1,694 lawsuits pending in a centralized Multi-District Litigation (MDL No. 2592) under Judge Eldon E. Fallon in the Eastern District of Louisiana.
The first “bellwether” trial dates have been set as early as August 2016 in Louisiana. The first two trials will take place in Louisiana, followed by trials in Texas and Mississippi.
The outcome of a “bellwether” trial is not binding on other lawsuits, but it can help lawyers negotiate a settlement or other resolution for cases involving similar injuries and allegations.
There is no known antidote to reverse the blood-thinning effects of Xarelto, which could be problematic in an emergency. Not even dialysis can remove it from a patient’s blood because Xarelto binds so tightly to proteins.
All of the lawsuits accuse Bayer and Janssen Pharmaceuticals of downplaying the risk of uncontrollable bleeding from Xarelto, while cherry-picking positive data for marketing purposes. Thousands of adverse events have been reported worldwide, including dozens of deaths.
When the FDA approved Xarelto in 2011, it was one of the first drugs in a new class of blood-thinners designed to replace warfarin (Coumadin). The difference is that warfarin can be reversed with a simple dose of Vitamin K and it has been on the market since the 1950s, with a well-established safety profile.
Need a Xarelto Lawyer in Texas?
Collen A. Clark is a true advocate for his clients and is passionate about helping Texans that have been injured or wronged.
Collen’s amazing success in the courtroom and well known dedication to his clients has earned him the recognition of his peers as one of The Top Trial Lawyers in Texas.”
The Clark Firm has assembled a team of trial lawyers with more than 100 years experience, participation in over 600 jury trials and $260 million in verdicts and/or settlements. Please use the form below to contact our Texas Xarelto lawyers for a free lawsuit review.